ABC | Volume 114, Nº5, Maio 2020

Arq Bras Cardiol. 2020; 114(5):943-987 Diretrizes Diretriz Brasileira de Reabilitação Cardiovascular – 2020 348. Hossri CAC, Felicioni SP, Lourenço UR. Exercise Testing in Patients with Cardiac Implantable Electronic Devices. Rev Bras Cardiol. 2014;27(3):217-27. 349. Cenik F, Schoberwalter D, Keilani M, Maehr B, Wolzt M, Marhold M, et al. Neuromuscular electrical stimulation of the thighs in cardiac patients with implantable cardioverter defibrillators. Wien Klin Wochenschr. 2016;128(21-22):802-8. 350. Pachón EIM. Interferência dos monitores de pulso pessoais nos portadores de marcapasso definitivo e desfibriladores. Reblampa. 2004;17(1):11-7. 351. Mizzaci C, Mastrocolla LE, Pineli S. Tutorial básico de marcapasso. Rev DERC. 2016;22(2):38-9. 352. Mizzaci C, Mastrocolla LE, Ruchler R, Buglia S. Tutorial básico de marcapasso – parte II: Wenckebach eletrônico (Wenckebach do marcapasso). Rev DERC. 2016;22(1):110-1. 353. MiracapilloG, Costoli A, Addonisio L, Breschi M, Pasquinelli K, Gemignani L, et al. Earlymobilization after pacemaker implantation. J CardiovascMed (Hagerstown). 2006;7(3):197-202. 354. Quittan M, Sochor A, Wiesinger GF, Kollmitzer J, Sturm B, Pacher R, et al. Strength improvement of knee extensor muscles in patients with chronic heart failure by neuromuscular electrical stimulation. Artif Organs. 1999;23(5):432-5. 355. Parissis J, Farmakis D, Karavidas A, Arapi S, Filippatos G, Lekakis J. Functional electrical stimulation of lower limb muscles as an alternative mode of exercise training in chronic heart failure: practical considerations and proposed algorithm. Eur J Heart Fail. 2015;17(12):1228-30. 356. Banerjee P, Caulfield B, Crowe L, Clark AL. Prolonged electrical muscle stimulationexercise improvesstrength,peakVO2,andexercisecapacity in patients with stable chronic heart failure. J Card Fail. 2009;15(4):319-26. 357. Aboyans V, Ricco JB, Bartelink ML, Bjorck M, Brodmann M, Cohner T, et al. [2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)]. Kardiol Pol. 2017;75(11):1065-160. 358. Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329-40. 359. Duff S, Mafilios MS, Bhounsule P, Hasegawa JT. The burden of critical limb ischemia: a review of recent literature. Vasc Health Risk Manag. 2019;15:187-208. 360. XuD, Zou L, Xing Y, Hou L, Wei Y, Zhang J, et al. Diagnostic value of ankle- brachial index in peripheral arterial disease: ameta-analysis. Can J Cardiol. 2013;29(4):492-8. 361. Aboyans V, Criqui MH, Abraham P, Allison MA, Creager MA, Diehm C, et al. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation. 2012;126(24):2890-909. 362. Kithcart AP, Beckman JA. ACC/AHA Versus ESC Guidelines for Diagnosis and Management of Peripheral Artery Disease: JACC Guideline Comparison. J Am Coll Cardiol. 2018;72(22):2789-801. 363. Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135(12):e686-e725. 364. Stivalet O, Paisant A, Belabbas D, Omarjee L, Le Faucheur A, Landreau P, et al. Exercise testing criteria to diagnose lower extremity peripheral artery disease assessed by computed-tomography angiography. PLoSOne. 2019;14(6):e0219082. 365. Lane R, Ellis B, Watson L, Leng GC. Exercise for intermittent claudication. Cochrane Database Syst Rev. 2014(7):CD000990. 366. FokkenroodHJ, Bendermacher BL, Lauret GJ,Willigendael EM, PrinsMH, Teijink JA. Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication. Cochrane Database Syst Rev. 2013(8):CD005263. 367. Gommans LN, Fokkenrood HJ, van Dalen HC, Scheltinga MR, Teijink JA, Peters RJ. Safety of supervised exercise therapy in patients with intermittent claudication. J Vasc Surg. 2015;61(2):512-8 e2. 368. Bermingham SL, Sparrow K, Mullis R, Fox M, Shearman C, Bradbury A, et al. The cost-effectiveness of supervised exercise for the treatment of intermittent claudication. Eur J Vasc Endovasc Surg. 2013;46(6):707-14. 369. Al-Jundi W, Madbak K, Beard JD, Nawaz S, Tew GA. Systematic review of home-based exercise programmes for individuals with intermittent claudication. Eur J Vasc Endovasc Surg. 2013;46(6):690-706. 370. Back M, Jivegard L, Johansson A, Nordanstig J, Svanberg T, Adania UW, et al. Home-based supervised exercise versus hospital-based supervised exercise or unsupervised walk advice as treatment for intermittent claudication: a systematic review. J Rehabil Med. 2015;47(9):801-8. 371. Lauret GJ, Fakhry F, Fokkenrood HJ, Hunink MG, Teijink JA, Spronk S. Modes of exercise training for intermittent claudication. Cochrane Database Syst Rev. 2014(7):CD009638. 372. Jakubseviciene E, Vasiliauskas D, Velicka L, Kubilius R, Milinaviciene E, Vencloviene J. Effectiveness of a new exercise program after lower limb arterial blood flow surgery in patients with peripheral arterial disease: a randomized clinical trial. Int J Environ Res Public Health. 2014;11(8):7961-76. 373. Kruidenier LM, Nicolai SP, Rouwet EV, Peters RJ, Prins MH, Teijink JA. Additional supervised exercise therapy after a percutaneous vascular intervention for peripheral arterial disease: a randomized clinical trial. J Vasc Interv Radiol. 2011;22(7):961-8. 374. Malgor RD, Alahdab F, Elraiyah TA, Rizvi AZ, Lane MA, Prokop LJ, et al. A systematic review of treatment of intermittent claudication in the lower extremities. J Vasc Surg. 2015;61(3 Suppl):54S-73S. 375. Murphy TP, Cutlip DE, Regensteiner JG, Mohler ER, Cohen DJ, Reynolds MR, et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation. 2012;125(1):130-9. 376. Murphy TP, Cutlip DE, Regensteiner JG, Mohler ER 3rd, Cohen DJ, Reynolds MR, et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. J Am Coll Cardiol. 2015;65(10):999-1009. 377. Klaphake S, Buettner S, Ultee KH, van Rijn MJ, Hoeks SE, Verhagen HJ. Combination of endovascular revascularization and supervised exercise therapy for intermittent claudication: a systematic review and meta- analysis. J Cardiovasc Surg (Torino). 2018;59(2):150-7. 378. Saratzis A, Paraskevopoulos I, Patel S, Donati T, Biasi L, Diamantopoulos A, et al. Supervised Exercise Therapy and Revascularization for Intermittent Claudication: Network Meta-Analysis of Randomized Controlled Trials. JACC Cardiovasc Interv. 2019;12(12):1125-36. 379. Arya S, Khakharia A, Binney ZO, DeMartino RR, Brewster LP, Goodney PP, et al. Association of Statin DoseWith Amputation and Survival in Patients With Peripheral Artery Disease. Circulation. 2018;137(14):1435-46. 380. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996;348(9038):1329-39. 381. Harwood AE, Smith GE, Cayton T, Broadbent E, Chetter IC. A Systematic Review of the Uptake and Adherence Rates to Supervised Exercise Programs in Patients with Intermittent Claudication. Ann Vasc Surg. 2016;34:280-9. 382. Lane R, Harwood A, Watson L, Leng GC. Exercise for intermittent claudication. Cochrane Database Syst Rev. 2017;12:CD000990. Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 987